Literature DB >> 15047790

Public funding of US syringe exchange programs.

Don C Des Jarlais1, Courtney McKnight, Judith Milliken.   

Abstract

Although there has been no federal government funding of syringe exchange, there is substantial state and local government funding. We report here on program characteristics associated with receiving state and local government funding. Annual telephone surveys were made of program directors of syringe exchange programs known to the North American Syringe Exchange Network. The number of syringe exchange programs known to this network has increased from 63 in 1994-1995 to 127 in 2000. Approximately 80% of programs participated in each of the surveys. Approximately 50% of programs receive state and local government funding, and this has remained constant from 1994 to 2000. Receiving state and local government funding was associated with larger numbers of syringes exchanged per year and providing more on-site services. Among programs that received state or local government funding, this funding accounted for a mean of 87% of the budget for syringe exchange services. In the absence of federal funding, state and local government support is associated with better syringe exchange performance.

Mesh:

Year:  2004        PMID: 15047790      PMCID: PMC3456139          DOI: 10.1093/jurban/jth093

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  6 in total

1.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

3.  HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.

Authors:  M MacDonald; A D Wodak; R Ali; N Crofts; P H Cunningham; K A Dolan; M Kelaher; W M Loxley; I van Beek; J M Kaldor
Journal:  Med J Aust       Date:  1997-03-03       Impact factor: 7.738

4.  HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Authors:  D C Des Jarlais; M Marmor; D Paone; S Titus; Q Shi; T Perlis; B Jose; S R Friedman
Journal:  Lancet       Date:  1996-10-12       Impact factor: 79.321

5.  HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-07-11       Impact factor: 17.586

6.  Maintaining low HIV seroprevalence in populations of injecting drug users.

Authors:  D C Des Jarlais; H Hagan; S R Friedman; P Friedmann; D Goldberg; M Frischer; S Green; K Tunving; B Ljungberg; A Wodak
Journal:  JAMA       Date:  1995-10-18       Impact factor: 56.272

  6 in total
  6 in total

1.  Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions.

Authors:  Valerie J Rose; Glenn Backes; Alexis Martinez; Willi McFarland
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

Review 2.  Structural interventions: concepts, challenges and opportunities for research.

Authors:  K M Blankenship; S R Friedman; S Dworkin; J E Mantell
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

3.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Authors:  Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell
Journal:  Int J Drug Policy       Date:  2008-03-04

4.  Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.

Authors:  Hannah L F Cooper; Joanne E Brady; Samuel R Friedman; Barbara Tempalski; Karla Gostnell; Peter L Flom
Journal:  J Urban Health       Date:  2008-08-16       Impact factor: 3.671

5.  Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

Authors:  Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper
Journal:  Ann Epidemiol       Date:  2014-01-24       Impact factor: 3.797

6.  'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.

Authors:  M Harris; R Brathwaite; Catherine R McGowan; D Ciccarone; G Gilchrist; M McCusker; K O'Brien; J Dunn; J Scott; V Hope
Journal:  Harm Reduct J       Date:  2018-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.